Lokon Pharma AB is a wholly owned subsidiariy of nxt2b (www.nxt2b.com), a leading venture capital company in Sweden by partnering with competent and ambitious entrepreneurs; focusing on growth equity investments in healthcare, medical devices and specialty pharmaceutical companies.
